Systemic delivery of targeted nanotherapeutic reverses angiotensin II-induced abdominal aortic aneurysms in mice
Abstract Abdominal aortic aneurysm (AAA) disease causes dilation of the aorta, leading to aortic rupture and death if not treated early. It is the 14th leading cause of death in the U.S. and 10th leading cause of death in men over age 55, affecting thousands of patients. Despite the prevalence of AA...
Enregistré dans:
Auteurs principaux: | Xiaoying Wang, Vaideesh Parasaram, Saphala Dhital, Nasim Nosoudi, Shahd Hasanain, Brooks A. Lane, Susan M. Lessner, John F. Eberth, Naren R. Vyavahare |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/895b007d529646f1a277f035ac199b80 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Author Correction: Systemic delivery of targeted nanotherapeutic reverses angiotensin II‑induced abdominal aortic aneurysms in mice
par: Xiaoying Wang, et autres
Publié: (2021) -
MFAP4 Deficiency Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysm Formation Through Regulation of Macrophage Infiltration and Activity
par: Bartosz Pilecki, et autres
Publié: (2021) -
CRP immunodeposition and proteomic analysis in abdominal aortic aneurysm.
par: Eun Na Kim, et autres
Publié: (2021) -
Antiphospholipid antibodies predict progression of abdominal aortic aneurysms.
par: Christina Duftner, et autres
Publié: (2014) -
Use of intravascular ultrasound in endovascular repair of abdominal aortic aneurysm
par: Łukasz Dzieciuchowicz, et autres
Publié: (2020)